Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
3.690
+0.140 (3.94%)
Nov 4, 2024, 4:00 PM EST - Market closed
Sutro Biopharma Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$12.13
Upside
+228.73%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Reiterates $11 | Buy | Reiterates | $11 | +198.10% | Oct 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +225.20% | Oct 11, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +360.70% | Sep 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +225.20% | Sep 16, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +306.50% | Aug 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +225.20% | Aug 14, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +171.00% | May 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +225.20% | May 14, 2024 |
Wedbush | Wedbush | Buy Reiterates $8 | Buy | Reiterates | $8 | +116.80% | May 14, 2024 |
B of A Securities | B of A Securities | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +225.20% | May 8, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +360.70% | Apr 3, 2024 |
Piper Sandler | Piper Sandler | Buy Reiterates $12 → $11 | Buy | Reiterates | $12 → $11 | +198.10% | Apr 3, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +171.00% | Apr 3, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $25 → $18 | Strong Buy | Maintains | $25 → $18 | +387.80% | Apr 3, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +171.00% | Mar 28, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +171.00% | Mar 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.